Home > Insider Trading > Filing (0001615774-18-006006)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1430306	Tonix Pharmaceuticals Holding Corp.	TNXP	Pharmaceutical Preparations (2834)	261434750

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1563420	Seth Lederman	C/O Tonix Pharmaceuticals Holding Corp. 509 Madison Avenue, Suite 306 New York NY 10022	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Acquisiton	2018-06-28	500	$4.58	17,166	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	22,700	Indirect	By 401(k) plan
Common Stock, $0.001 Par Value	45,900	Indirect	By IRA account
Common Stock, $0.001 Par Value	3,100	Indirect	By spouse
Common Stock, $0.001 Par Value	2,917	Indirect	By Leder Laboratories, Inc.
Common Stock, $0.001 Par Value	2,917	Indirect	By Starling Pharmaceuticals, Inc.
Common Stock, $0.001 Par Value	20,463	Indirect	By Lederman & Co., LLC
Common Stock, $0.001 Par Value	3,246	Indirect	By L&L Technologies, LLC
Common Stock, $0.001 Par Value	5,898	Indirect	By Targent Pharmaceuticals, LLC

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.57 to $4.59 per share, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp. ("Tonix"), any security holder of Tonix, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
Reporting person may be deemed to be a control person of this entity.